Low density biodegradable pha-based resins for injection molding
Innovative PHA-based resins for injection molding offer reduced density, enhanced mechanical properties, and biodegradability. These resins are suitable for rigid containers, threads, and closures, utilizing reactive extrusion and foaming agents for improved performance.
Overview
The University of Queensland Frazer Institute has developed a cutting-edge solution for creating low-density, biodegradable PHA-based resins designed for injection molding. This innovative material offers a sustainable alternative to traditional plastics, featuring enhanced mechanical properties suitable for rigid containers, threads, and closures. By integrating proven toughening technology and foaming agents, these resins provide superior thermal insulation and shock absorption, while maintaining water resistance and flexibility.
Technical specifications
The resin formulations are based on fifteen years of research into PHA modification and downstream processing. Key features include:
- Biodegradability: Completely biodegradable and non-toxic, offering an eco-friendly packaging solution.
- Mechanical Properties: Enhanced toughness, impact resistance, and flexibility for various applications.
- Reactive Extrusion: Utilizes reactive extrusion with active foaming agents, triggered by injection molding temperatures, to achieve desired densities.
- Tailored Formulations: Customizable properties through the blend of different PHA types and biodegradable additives.
Technology readiness level
Currently at Technology Readiness Level 3, the project has proven concepts and is undergoing further formulation and validation. Initial foaming trials are expected to take approximately three months, with subsequent formulation enhancements over six months. Recyclability and biodegradability testing will follow, requiring an additional 3-6 months depending on the scope of mineralization testing.
About The University of Queensland
The University of Queensland is a large, multi-campus public research university in Brisbane with a comprehensive academic and research profile. Industry partners engage through hospital-embedded laboratories and clinical sites, pilot testbeds, and field campuses across Queensland that enable prototyping, trials, and validation in real-world settings. Co-location with major health precincts and proximity to Brisbane’s innovation districts make collaboration and talent access straightforward, while on-campus incubation and professional education support workforce upskilling. Research is supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, alongside state and industry investment. A dedicated technology transfer office and commercialization company manage IP, licensing, sponsored research agreements, and spin-out formation.
delivered to your inbox.